Greenwich Wealth Management LLC boosted its position in shares of Lumos Pharma, Inc. (NASDAQ:LUMO – Free Report) by 55.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 76,341 shares of the company’s stock after acquiring an additional 27,339 shares during the period. Greenwich […]